In a recent study, Wang et al. demonstrated that within the NAFLD model, CAMKKβ functions as the initiating kinase for the AMPK-mediated antioxidant defense mechanism, which protect hepatocytes from lipotoxicity [33]. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.